These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 10150049)

  • 1. Radionuclear assessment in ischemic heart disease.
    Machac J
    Curr Opin Cardiol; 1990 Aug; 5(4):397-402. PubMed ID: 10150049
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evaluation of myocardial viability by isotopic methods].
    Latre Romero JM; Vallés Belsué F
    Rev Esp Cardiol; 1994; 47 Suppl 4():116-23. PubMed ID: 7863076
    [No Abstract]   [Full Text] [Related]  

  • 3. Perfusion imaging in ischemic heart disease.
    Rivitz SM; Deluca SA
    Am Fam Physician; 1993 Nov; 48(6):1071-8. PubMed ID: 8237730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of nuclear imaging in ischemic heart disease.
    Iskandrian AS; Juweid M; Heo J
    Curr Opin Cardiol; 1993 Jul; 8(4):562-71. PubMed ID: 10150122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current and future developments in scintigraphy to assess myocardial perfusion and function.
    Lim A; Goldschlager N
    Am J Card Imaging; 1992 Mar; 6(1):83-92. PubMed ID: 10150085
    [No Abstract]   [Full Text] [Related]  

  • 6. Myocardial perfusion imaging.
    Grégoire J; Taillefer R
    Curr Opin Radiol; 1990 Dec; 2(6):815-22. PubMed ID: 2282257
    [No Abstract]   [Full Text] [Related]  

  • 7. New ways to scan the myocardium.
    Med Lett Drugs Ther; 1991 Sep; 33(853):87-9. PubMed ID: 1832204
    [No Abstract]   [Full Text] [Related]  

  • 8. Detection of coronary artery disease by dipyridamole thallium tomography in mitral valve stenosis.
    Huikuri HV; Airaksinen KE; Ikäheimo MJ; Korhonen UR; Heikkilä J; Takkunen JT
    Am J Cardiol; 1989 Jan; 63(1):124-6. PubMed ID: 2783295
    [No Abstract]   [Full Text] [Related]  

  • 9. Tomographic thallium-201 myocardial perfusion scintigrams after maximal coronary artery vasodilation with intravenous dipyridamole. Comparison of qualitative and quantitative approaches.
    Francisco DA; Collins SM; Go RT; Ehrhardt JC; Van Kirk OC; Marcus ML
    Circulation; 1982 Aug; 66(2):370-9. PubMed ID: 6980061
    [No Abstract]   [Full Text] [Related]  

  • 10. Technetium-labeled myocardial perfusion agents.
    Heo J; Iskandrian AS
    Cardiol Clin; 1994 May; 12(2):187-98. PubMed ID: 8033172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial perfusion imaging in ischemic heart disease anno 1990.
    Wackers FJ
    Curr Opin Cardiol; 1991 Aug; 6(4):590-601. PubMed ID: 10150064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New directions in myocardial perfusion imaging.
    Beller GA
    Clin Cardiol; 1993 Feb; 16(2):86-94. PubMed ID: 8435933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of dipyridamole-induced transient dilation of the left ventricle during thallium-201 scintigraphy in suspected coronary artery disease.
    Chouraqui P; Rodrigues EA; Berman DS; Maddahi J
    Am J Cardiol; 1990 Sep; 66(7):689-94. PubMed ID: 2399884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current status of nuclear cardiology techniques.
    Beller GA
    Curr Probl Cardiol; 1991 Jul; 16(7):451-535. PubMed ID: 1954752
    [No Abstract]   [Full Text] [Related]  

  • 15. Different tracers and stressors in patients with coronary artery disease: how to standardize clinical questions and nuclear cardiology answers.
    Marzullo P; Sambuceti G; Gimelli A; Giorgetti A; Parodi O
    J Nucl Biol Med (1991); 1994 Dec; 38(4):566-72. PubMed ID: 7786918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tomographic myocardial perfusion imaging with technetium-99m-teboroxime at rest and after dipyridamole.
    Li QS; Solot G; Frank TL; Wagner HN; Becker LC
    J Nucl Med; 1991 Oct; 32(10):1968-76. PubMed ID: 1919740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current and emerging scintigraphic methods to assess myocardial viability and their clinical importance.
    Iskandrian AS; Heo J; Nguyen T
    Am J Card Imaging; 1992 Mar; 6(1):16-26; discussion 27. PubMed ID: 10150084
    [No Abstract]   [Full Text] [Related]  

  • 18. Measurement of myocardial blood flow by radiolabeled tracers.
    Wilson RA
    J Nucl Med; 1993 Sep; 34(9):1518-9. PubMed ID: 8355073
    [No Abstract]   [Full Text] [Related]  

  • 19. [Evaluation of ischemic myocardium with regional time-activity curve of Tl-201].
    Katsuki T; Iino T; Toyosaki N; Natsume T; Yaginuma T; Hosoda S; Kawamura Y; Misawa I; Furuse M
    Kaku Igaku; 1987 Oct; 24(10):1547-56. PubMed ID: 3502010
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of maintenance oral theophylline on dipyridamole-thallium-201 myocardial imaging using SPECT and dipyridamole-induced hemodynamic changes.
    Daley PJ; Mahn TH; Zielonka JS; Krubsack AJ; Akhtar R; Bamrah VS
    Am Heart J; 1988 Jun; 115(6):1185-92. PubMed ID: 3259827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.